Alembic Pharmaceuticals (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivosidenib Tablets, 250 mg. The approved ANDA is therapeutica
![Alembic Pharmaceuticals receives USFDA tentative approval for Ivosidenib Tablets](https://img.easybranches.com/uploads/news/2024/07/alembic-pharmaceuticals-receives-usfda-tentative-approval-for-ivosidenib-tablets.jpg)
Related
Share this page
Guest Posts by Easy BranchesGet Reliable Matka Guessing Forum with our Satta Matka Expert and Get all Matka Chart For Free.